Search Symbol

Most Active Stocks

NIACL

HDFCBANK

DMART

VBL

TATAMOTORS

ICICIBANK

JAYNECOIND

RELIANCE

BHARTIARTL

EBGNG

AXISBANK

TCS

INFY

WAAREEENER

AMBER

KOTAKBANK

M&M

SBIN

INDIGO

Suven Life Sciences Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candidates include Masupirdine (SUVN-502) for the treatment of Alzheimer disease and neuropsychiatric symptoms; Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and Ropanicant (SUVN-911), Alpha4Beta2 nAChRs receptor antagonist for the treatment of depressive disorders. The company is developing Usmarapride (SUVN-D4010), a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.

Key Information

Market Cap

65878130688

Current Price

289.88

52 Week Range

102.5 - 299.99

Previous Close

286.4

Open

286.4

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Contact Details

Address

8-2-334, SDE Serene Chambers, 6th Floor Road No.5, Avenue 7 Banjara Hills, Hyderabad, 500034, India

Phone

+91-40235-41142

Fax

+91-40235-41152

Website

https://www.suven.com

Financials

Day Low

283.0

Day High

292.0

Dividend Yield

PE Ratio

Earnings Per Share

-7.36

Beta

0.817

EBITDA

-1522297984

Book Value

5.056

EPS

Company Officers

Name	Title	Age	Year Born
Mr. Venkateswarlu Jasti M.Pharm. M.S.	CEO, MD & Executive Chairman	75	1949
Ms. Sudharani Jasti B.Sc.	Whole-Time Director	70	1954
Mr. M. Mohan Kumar C.M.A.	Chief Financial Officer	-	-
Mr. Kundan Kumar Jha	Company Secretary & Compliance Officer	-	-
Ms. Kalyani Jasti	President of US Operations	45	1979